Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
CH:BSLN
Stock Latest News
Company Announcements
Basilea Pharmaceutica Earnings Call Signals Confident Growth
8d ago
Premium
Company Announcements
Basilea lifts 2026 profit outlook as anti-infectives pipeline and Cresemba sales power H1 results
8d ago
Premium
Company Announcements
Basilea Wins More BARDA Funding for Novel Oral Antibiotic Targeting Drug‑Resistant UTIs
21d ago
Premium
Company Announcements
BARDA injects $30 million into Basilea’s phase 3 antifungal program
28d ago
Premium
Company Announcements
Basilea Wins Fresh BARDA Funding for Novel Oral Antibiotic to Tackle Drug-Resistant UTIs
3M ago
Premium
Company Announcements
Basilea Wins CARB-X Funding Boost for First-in-Human Trial of Novel Antibiotic BAL2420
5M ago
Premium
Company Announcements
Basilea Wins BARDA Funding to Advance Novel Oral Antibiotic for Drug-Resistant UTIs
6M ago
Premium
Company Announcements
Basilea Pharmaceutica Earnings Call Highlights Pipeline Push
6M ago
Premium
Company Announcements
Basilea boosts revenues, triples net cash as anti‑infective pipeline advances
6M ago
Premium
Company Announcements
Basilea Pharmaceutica Completes Key Study on Fosmanogepix in Hepatic Impairment
8M ago
BSLN
Premium
Ratings
Basilea Pharmaceutica’s Strategic AI Partnership and Antifungal Growth Drive Buy Rating
9M ago
Premium
Company Announcements
Basilea Achieves Sales Milestone with Cresemba in Europe
10M ago
Premium
Company Announcements
Basilea Secures BARDA Funding for Novel Antibiotic Development
11M ago
Premium
Ratings
Basilea Pharmaceutica’s Strategic Expansion and Financial Backing Earns Buy Rating
11M ago
Premium
Company Announcements
Basilea Secures Additional BARDA Funding for Antifungal Development
11M ago
Premium
Company Announcements
Basilea’s Phase 3 Study on Fosmanogepix: A Potential Game-Changer in Antifungal Treatment
12M ago
BSLN
Premium
Company Announcements
Basilea Pharmaceutica’s Earnings Call Highlights Growth and Challenges
12M ago
Premium
Company Announcements
Basilea Pharmaceutica’s Phase 3 Study on Fosmanogepix: A Potential Game-Changer in Antifungal Treatment
12M ago
BSLN
Premium
Company Announcements
Basilea Pharmaceutica Reports Strong Financial Growth and Strategic Milestones in H1 2025
1y ago
Premium
Company Announcements
Basilea Pharmaceutica’s Phase 3 Trial: A Potential Game-Changer in Antifungal Treatment
1y ago
Premium
Company Announcements
Basilea Pharmaceutica Expands Pipeline with New Antibiotic License
1y ago
Premium
Company Announcements
Basilea Pharmaceutica’s Phase 3 Study on Fosmanogepix: A Potential Game-Changer in Antifungal Treatments
1y ago
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
